Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 21 of 21 entries
Sorted by: Best Match Show Resources per page
Medical management of silent ischemia and myocardial infarction.

The American journal of cardiology

Morris JJ.
PMID: 3341193
Am J Cardiol. 1988 Jan 29;61(3):1B-3B. doi: 10.1016/0002-9149(88)91346-x.

No abstract available.

Cite
Morris JJ. Medical management of silent ischemia and myocardial infarction. Am J Cardiol. 1988;61(3):1B-3Bdoi: 10.1016/0002-9149(88)91346-x.
Morris, J. J. (1988). Medical management of silent ischemia and myocardial infarction. The American journal of cardiology, 61(3), 1B-3B. https://doi.org/10.1016/0002-9149(88)91346-x
Morris, J J. "Medical management of silent ischemia and myocardial infarction." The American journal of cardiology vol. 61,3 (1988): 1B-3B. doi: https://doi.org/10.1016/0002-9149(88)91346-x
Morris JJ. Medical management of silent ischemia and myocardial infarction. Am J Cardiol. 1988 Jan 29;61(3):1B-3B. doi: 10.1016/0002-9149(88)91346-x. PMID: 3341193.
Copy Download .nbib Format: NLM
Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction.

Circulation

Albert MA.
PMID: 24326989
Circulation. 2014 Feb 18;129(7):723-4. doi: 10.1161/CIRCULATIONAHA.113.007322. Epub 2013 Dec 10.

No abstract available.

Cite
Albert MA. Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation. 2013;129(7):723-4doi: 10.1161/CIRCULATIONAHA.113.007322.
Albert, M. A. (2014). Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation, 129(7), 723-4. https://doi.org/10.1161/CIRCULATIONAHA.113.007322
Albert, Michelle A. "Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction." Circulation vol. 129,7 (2014): 723-4. doi: https://doi.org/10.1161/CIRCULATIONAHA.113.007322
Albert MA. Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation. 2014 Feb 18;129(7):723-4. doi: 10.1161/CIRCULATIONAHA.113.007322. Epub 2013 Dec 10. PMID: 24326989.
Copy Download .nbib Format: NLM
Myocardial infarction and mental illness.

Journal of the Royal Society of Medicine

Pappworth MH.
PMID: 3656323
J R Soc Med. 1987 Jul;80(7):464-5.
Free PMC Article

No abstract available.

Cite
Pappworth MH. Myocardial infarction and mental illness. J R Soc Med. 1987;80(7):464-5
Pappworth, M. H. (1987). Myocardial infarction and mental illness. Journal of the Royal Society of Medicine, 80(7), 464-5.
Pappworth, M H. "Myocardial infarction and mental illness." Journal of the Royal Society of Medicine vol. 80,7 (1987): 464-5.
Pappworth MH. Myocardial infarction and mental illness. J R Soc Med. 1987 Jul;80(7):464-5. PMID: 3656323; PMCID: PMC1290918.
Copy Download .nbib Format: NLM
[Acute therapy of uncomplicated myocardial infarct].

Deutsche medizinische Wochenschrift (1946)

Pantlen H.
PMID: 7351178
Dtsch Med Wochenschr. 1980 Jan;105(3):100.

No abstract available.

Cite
Pantlen H. Akuttherapie des unkomplizierten Herzinfarktes. [Acute therapy of uncomplicated myocardial infarct]. Dtsch Med Wochenschr. 1980;105(3):100
Pantlen, H. (1980). Akuttherapie des unkomplizierten Herzinfarktes. [Acute therapy of uncomplicated myocardial infarct]. Deutsche medizinische Wochenschrift (1946), 105(3), 100.
Pantlen, H. "Akuttherapie des unkomplizierten Herzinfarktes." [Acute therapy of uncomplicated myocardial infarct]. Deutsche medizinische Wochenschrift (1946) vol. 105,3 (1980): 100.
Pantlen H. Akuttherapie des unkomplizierten Herzinfarktes. [Acute therapy of uncomplicated myocardial infarct]. Dtsch Med Wochenschr. 1980 Jan;105(3):100. German. PMID: 7351178.
Copy Download .nbib Format: NLM
Management of acute myocardial infarction patients.

Journal of the Mississippi State Medical Association

Rosenblatt WH.
PMID: 5900407
J Miss State Med Assoc. 1966 Jan;7(1):15-6.

No abstract available.

Cite
Rosenblatt WH. Management of acute myocardial infarction patients. J Miss State Med Assoc. 1966;7(1):15-6
Rosenblatt, W. H. (1966). Management of acute myocardial infarction patients. Journal of the Mississippi State Medical Association, 7(1), 15-6.
Rosenblatt, W H. "Management of acute myocardial infarction patients." Journal of the Mississippi State Medical Association vol. 7,1 (1966): 15-6.
Rosenblatt WH. Management of acute myocardial infarction patients. J Miss State Med Assoc. 1966 Jan;7(1):15-6. PMID: 5900407.
Copy Download .nbib Format: NLM
Mortality after myocardial infarction.

JAMA

Zumoff B.
PMID: 6823040
JAMA. 1983 Feb 18;249(7):885.

No abstract available.

Cite
Zumoff B. Mortality after myocardial infarction. JAMA. 1983;249(7):885
Zumoff, B. (1983). Mortality after myocardial infarction. JAMA, 249(7), 885.
Zumoff, B. "Mortality after myocardial infarction." JAMA vol. 249,7 (1983): 885.
Zumoff B. Mortality after myocardial infarction. JAMA. 1983 Feb 18;249(7):885. PMID: 6823040.
Copy Download .nbib Format: NLM
Company profile: Athersys.

Regenerative medicine

Van Bokkelen G.
PMID: 21175285
Regen Med. 2011 Jan;6(1):39-43. doi: 10.2217/rme.10.90.

Athersys (Nasdaq: ATHX) is a biopharmaceutical company engaged in the discovery and development of novel therapies designed to treat significant unmet medical needs. The company is heavily focused on the regenerative medicine area, with multiple clinical and preclinical stage...

Cite
Van Bokkelen G. Company profile: Athersys. Regen Med. 2011;6(1):39-43doi: 10.2217/rme.10.90.
Van Bokkelen, G. (2011). Company profile: Athersys. Regenerative medicine, 6(1), 39-43. https://doi.org/10.2217/rme.10.90
Van Bokkelen, Gil. "Company profile: Athersys." Regenerative medicine vol. 6,1 (2011): 39-43. doi: https://doi.org/10.2217/rme.10.90
Van Bokkelen G. Company profile: Athersys. Regen Med. 2011 Jan;6(1):39-43. doi: 10.2217/rme.10.90. PMID: 21175285.
Copy Download .nbib Format: NLM
[Medical treatment].

Nihon rinsho. Japanese journal of clinical medicine

Sakai T.
PMID: 22724194
Nihon Rinsho. 2011 Nov;69:156-61.

No abstract available.

Cite
Sakai T. [Medical treatment]. Nihon Rinsho. 2011;69:156-61
Sakai, T. (2011). [Medical treatment]. Nihon rinsho. Japanese journal of clinical medicine, 69156-61.
Sakai, Tetsuo. "[Medical treatment]." Nihon rinsho. Japanese journal of clinical medicine vol. 69 (2011): 156-61.
Sakai T. [Medical treatment]. Nihon Rinsho. 2011 Nov;69:156-61. Japanese. PMID: 22724194.
Copy Download .nbib Format: NLM
Targeted nanoscale therapeutics for myocardial infarction.

Biomaterials science

Sullivan HL, Gianneschi NC, Christman KL.
PMID: 33367371
Biomater Sci. 2021 Feb 21;9(4):1204-1216. doi: 10.1039/d0bm01677b. Epub 2020 Dec 23.

Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally invasive routes is critical to this promise. In this...

Cite
Sullivan HL, Gianneschi NC, Christman KL. Targeted nanoscale therapeutics for myocardial infarction. Biomater Sci. 2020;9(4):1204-1216doi: 10.1039/d0bm01677b.
Sullivan, H. L., Gianneschi, N. C., & Christman, K. L. (2021). Targeted nanoscale therapeutics for myocardial infarction. Biomaterials science, 9(4), 1204-1216. https://doi.org/10.1039/d0bm01677b
Sullivan, Holly L, et al. "Targeted nanoscale therapeutics for myocardial infarction." Biomaterials science vol. 9,4 (2021): 1204-1216. doi: https://doi.org/10.1039/d0bm01677b
Sullivan HL, Gianneschi NC, Christman KL. Targeted nanoscale therapeutics for myocardial infarction. Biomater Sci. 2021 Feb 21;9(4):1204-1216. doi: 10.1039/d0bm01677b. Epub 2020 Dec 23. PMID: 33367371; PMCID: PMC7932032.
Copy Download .nbib Format: NLM
Showing 13 to 21 of 21 entries